noun a term used in the pharmaceutical industry to describe the period when multiple patents for blockbuster drugs expire, allowing generic versions to enter the market
Describes the economic impact of patent expirations on companies, industries, and overall market dynamics.
Involves planning for the impact of patent expirations on a company's revenue and market position, often requiring diversification or innovation to offset the loss.
Describes the situation where a biotech company faces a decline in revenue as patents on its key products expire, allowing competitors to enter the market with generic versions.
Refers to a period during which a pharmaceutical company's patents on key drugs expire, leading to a significant drop in revenue due to generic competition.
Refers to the phenomenon of multiple patents expiring in a short period, leading to a 'cliff' in revenue for the patent holders.
In the pharmaceutical industry, a writer may discuss the concept of a 'patent cliff' in articles or reports detailing the impact of expiring patents on drug companies.
A psychologist may study the psychological effects of a 'patent cliff' on employees of pharmaceutical companies facing revenue losses due to expired patents.
A business analyst may analyze the financial implications of a 'patent cliff' on a specific industry, such as healthcare, and provide recommendations for companies to navigate this period of decreased revenue.
A lawyer specializing in intellectual property law may advise pharmaceutical companies on strategies to protect their patents and navigate the challenges posed by a 'patent cliff' in the industry.